Free Trial

Sorrento Therapeutics (SRNE) News Today

Sorrento Therapeutics logo
$0.0040
0.00 (0.00%)
(As of 11/4/2024 ET)
Sorrento Therapeutics Inc (SRNE)
Sorrento Therapeutics Inc SRNE
Sorrento Therapeutics, Inc. stock logo
Sorrento Therapeutics (NASDAQ:SRNE) Stock Price Passes Below 200 Day Moving Average of $0.11
Sorrento Therapeutics (NASDAQ:SRNE) Stock Crosses Below 200 Day Moving Average of $0.11
Sorrento Therapeutics, Inc. (0L85.L)
Sorrento Therapeutics Inc SRNEQ
SRNEQ Sorrento Therapeutics, Inc.
Sorrento Therapeutics (OTC: SRNE.Q)
Sorrento Therapeutics, Inc. stock logo
UBS Group AG Has $2.12 Million Stock Position in Sorrento Therapeutics, Inc. (NASDAQ:SRNE)
UBS Group AG increased its stake in shares of Sorrento Therapeutics, Inc. (NASDAQ:SRNE - Get Rating) by 916.0% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 2,383,825 shares of the biopharmaceutical company's stock after acquiring an addi
Sorrento Therapeutics, Inc. (SRNEQ)
Sorrento Therapeutics, Inc. stock logo
Sorrento Therapeutics, Inc. (NASDAQ:SRNE) Shares Bought by Credit Suisse AG
Credit Suisse AG grew its holdings in Sorrento Therapeutics, Inc. (NASDAQ:SRNE - Get Rating) by 260.4% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,026,474 shares of the biopharmaceutical company's stock after buying
Why Sorrento Therapeutics Stock Is Soaring Today
Sorrento Therapeutics Files For Bankruptcy
Sorrento Therapeutics Stock Is Sinking: What's Going On?
Sorrento Therapeutics, Inc. stock logo
Sorrento Therapeutics, Inc. (NASDAQ:SRNE) Shares Bought by Victory Capital Management Inc.
Victory Capital Management Inc. increased its holdings in Sorrento Therapeutics, Inc. (NASDAQ:SRNE - Get Rating) by 136.0% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 281,357 shares of the biopharmaceutic
Sorrento Therapeutics, Inc. stock logo
SG Americas Securities LLC Has $84,000 Holdings in Sorrento Therapeutics, Inc. (NASDAQ:SRNE)
SG Americas Securities LLC trimmed its position in shares of Sorrento Therapeutics, Inc. (NASDAQ:SRNE - Get Rating) by 87.1% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 53,722 shares of the biopharmaceu
5 Hot Healthcare Stocks to Buy Now
Sorrento Therapeutics, Inc. stock logo
Raymond James & Associates Increases Stock Holdings in Sorrento Therapeutics, Inc. (NASDAQ:SRNE)
Raymond James & Associates boosted its stake in Sorrento Therapeutics, Inc. (NASDAQ:SRNE - Get Rating) by 65.1% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 257,319 shares of the biopharmaceutical company'
Sorrento Therapeutics, Inc. stock logo
Barclays PLC Purchases 1,829,031 Shares of Sorrento Therapeutics, Inc. (NASDAQ:SRNE)
Barclays PLC increased its position in shares of Sorrento Therapeutics, Inc. (NASDAQ:SRNE - Get Rating) by 1,097.7% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,995,651 shares of the biopharmaceutical company's s
Get Sorrento Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for SRNE and its competitors with MarketBeat's FREE daily newsletter.

Ticking time bomb. Detonation Nov 5 (Ad)

Porter Stansberry’s viral Breaking Point 2024 broadcast has now been by tens of thousands of Americans who finally understand the grim reality of our next election. With November 5 just around the corner, it’s imperative for your financial future that you read Porter’s message below now and then watch Breaking Point before it’s too late.

Watch this video, it is being taken down Monday night

SRNE Media Mentions By Week

SRNE Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

SRNE
News Sentiment

0.00

0.46

Average
Medical
News Sentiment

SRNE News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

SRNE Articles
This Week

0

0

SRNE Articles
Average Week

Get Sorrento Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for SRNE and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:SRNE) was last updated on 11/4/2024 by MarketBeat.com Staff
From Our Partners